The MOG-IgG- group had a clinical diagnosis as follows: 25.9% had ON, 27.6% had myelitis, 3.5% were clinically diagnosed with seronegative NMOSD, 5.2% were diagnosed with AQP4-NMOSD. Here, AQP4 is linked to myelitis.